The WHO COVID-19 Essential Supplies Forecasting Tool (COVID-19-ESFT) is meant to help countries forecast essential supplies for their COVID-19 response including personal protective equipment (e.g., masks and gloves), biomedical equipment for case management (e.g., ventilators and oxygen concentrato...rs), diagnostic reagents and equipment, essential drugs for supportive care, and consumable medical supplies.
The tool is best suited for estimating essential supply needs over a short time period (12 weeks or fewer) but can be used for longer.
COVID-19-ESFT does not quantify or account for resources already available locally or those pending delivery. When using the ESFT to inform procurement, we recommend factoring in resources already available locally and only including the additional resources required in the forecast.
This tool is updated regularly so users should monitor the website for the latest release version.
more
Mozambique registered its first COVID-19 case on 22 March 2020 and since then numbers have steadily grown over the following three months with cases now reported in all provinces. In response, a level 3 State of emergency was enacted on 1 April 2020 and has been extended until 29 July 2020, with mea...sures targeting the prevention of COVID-19 transmissions.
more
Accessed on 20.10.2020
L͛analyse des tendances récentes montre que le Burkina Faso a enregistré une réduction significative de la mortalité infanto-juvénile. Même si aucune des cibles des OMD 4 et 5 n͛a été atteinte par le pays, le taux de mortalité infanto-juvénile est passé de 129 ...pour mille naissances vivantes en 2010 à 82 pour mille naissances
vivantes en 2015, soit une baisse de 7.3% par an. Ceci est en grande partie dû aux progrès enregistrés en matière de lutte contre la mortalité au bénéfice de la tranche juvénile (de 1 à 4 ans). Cependant, comme près de la moitié des enfants âgés de moins de cinq ans continuent de mourir au cours de leur première
année de vie, il reste beaucoup à faire pour l͛atteinte de la vision globale d͛élimination de la mortalité infanto-juvénile évitable et de réduction de la mortalité des mères comme partie prenante des Objectifs de Développement Durable (ODD).
more
New research explores the stress children in World Vision programmes in the Middle East and Eastern Europe region are under due to COVID-19. In addition to their fear that they themselves or their loved ones will catch the disease, children worry about economic hardships, the loss of their education..., increased violence and social isolation. But in the midst of it all, a clear message comes through – young people are hopeful about the future, they want to make a contribution and they want their voices to be heard.
more
The present Community Empowerment Manual draws upon the lessons learned of the Community Protection Approach implementation in Lebanon, the occupied Palestinian territory and Central America during the period 2015-2020 by WeWorld – GVC and its partners.
The Manual means to accompany Field Staff i...n devising the most appropriate strategy to engage with communities, given the conditions of access, security and time of the specific context in which a project is implemented. Even though the steps described proceed alongside the implementation of the Community Protection Approach, the manual has different sections providing guidance for the definition of engagement strategies in any context or project in question.
more
Consolidating Earthquake Safety Assessment Efforts in India. This document provides succinct instructions on how to perform rapid visual screening (RVS), a quick method of earthquake assessment of buildings. It covers a brief description of RVS and its role as a simplified qualitative assessment in ...the wider methodology of earthquake assessment of buildings, and the recommended forms for pre-earthquake and post-earthquake Level 1 Assessments for seven building typologies. The method recommended by the primer is the BMTPC method which provides both Seismic Safety Index and Performance Rating to a particular building.
more
Hypertension and COVID-19: Scientific report - 17 June 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021